Abstract
Besides its usual symptoms, allergic rhinitis has a substantial negative influence on one's physical and emotional well-being as well as social and mental interactions and overall Quality of Life (QOL). Environmental causes and changes in lifestyle are contributing to its rising global incidence. Nasal congestion symptoms can make it difficult to sleep, wear you out, and interfere with everyday activities, especially when they coexist with other disorders like asthma. Studies have demonstrated the efficacy of medication and variations in prevalence according to gender. This research attempts to assess the effects of allergic rhinitis on quality of life in detail. Pharmacotherapy and avoiding allergens are the best forms of treatment. When appropriate, targeted symptom control with immunotherapy and an assessment for allergic rhinitis should be taken into account.
Patients with allergic rhinitis are treated with decongestants, immunotherapy, anticholinergic drugs, corticosteroids, and antihistamines. The most effective and often used drugs are these antihistamines and intranasal corticosteroids. Studies have shown that people with allergic rhinitis who take both of these drugs experience improvements in their quality of life. The disease's overall burden extends beyond functional limitations in the body and society. It also has a financial impact, which increases when we take into account the data suggesting that allergic rhinitis may be the cause of comorbid conditions like sinusitis and asthma. The most common symptom, nasal blockage, is linked to sleep difficulties, which can have a significant impact on behavior, learning, mental health, and attention.
No comments:
Post a Comment